{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:52:09Z","timestamp":1763016729124},"reference-count":18,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T00:00:00Z","timestamp":1168387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A 74\u2010year\u2010old lady who presented initially with loin pain and haematuria, then melaena was found to have a prothrombin time ratio (PTR)\u2003&gt;\u200310 and activated partial thromboplastin time ratio (APTTR)\u2003&gt;\u20037. A factor V inhibitor was diagnosed. She was managed with supportive care and the FV inhibitor resolved. A few weeks later she developed abdominal swelling and ascites and was found to have an ovarian tumour. This is the first case, as far as we are aware, of a malignancy\u2010associated FV antibody that has spontaneously remitted before overt presentation of the tumour and illustrates the value of adopting an expectant approach to the management of acquired FV inhibitors.<\/jats:p>","DOI":"10.1111\/j.1365-2257.2006.00873.x","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T09:14:28Z","timestamp":1168420468000},"page":"316-319","source":"Crossref","is-referenced-by-count":9,"title":["Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma"],"prefix":"10.1111","volume":"29","author":[{"given":"E. O.","family":"MAUGHAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"WILSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T.","family":"WILDE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,10]]},"reference":[{"key":"e_1_2_3_2_1","first-page":"1664","article-title":"A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA: with bibliographic review","volume":"21","author":"Abe T.","year":"1980","journal-title":"Rinsho Ketsueki. Japanese Journal of Clinical Hematology"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03343.x"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10172"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V56.5.835.835"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<315::AID-AJH11>3.0.CO;2-D"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02510.x"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8191.2000.tb01296.x"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01014.x"},{"key":"e_1_2_3_10_1","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1016\/S0021-9258(17)38006-7","article-title":"Properties of the factor Xa binding site on human platelets","volume":"253","author":"Miletich J.P.","year":"1978","journal-title":"The Journal of Biological Chemistry"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112318"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(99)90062-8"},{"key":"e_1_2_3_13_1","first-page":"1426","article-title":"Acquired factor V inhibitors showing positive platelet neutralisation test and responding to platelet transfusions. Report of four cases [abstract]","volume":"73","author":"Raman B.K.S.","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10420"},{"key":"e_1_2_3_15_1","first-page":"1223","article-title":"Acquired factor V inhibitor clinically well tolerated: a 3\u2003years follow\u2010up [abstract]","volume":"77","author":"Rugeri L.","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00011.x"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-02-0141"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200301000-00016"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25185116503.x"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2257.2006.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2257.2006.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T13:51:34Z","timestamp":1697032294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2257.2006.00873.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1365-2257.2006.00873.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2257.2006.00873.x","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,10]]}}}